A Study to Evaluate the Efficacy and Safety of Celecoxib Suspension Compared to Naproxen Suspension in Patients With JRA

PHASE3CompletedINTERVENTIONAL
Enrollment

225

Participants

Timeline

Start Date

October 31, 2002

Primary Completion Date

April 30, 2004

Study Completion Date

April 30, 2005

Conditions
Arthritis, Juvenile Rheumatoid
Interventions
DRUG

Celecoxib

Higher dose, 6 mg/kg/dose BID

DRUG

Celecoxib

Active drug at lower dose

DRUG

Naproxen

Control comparator, 15 mg/kg/dy target dose

Trial Locations (58)

1525

Pfizer Investigational Site, Ljubljana

3000

Pfizer Investigational Site, Leuven

8200

Pfizer Investigational Site, Århus N

10032

Pfizer Investigational Site, New York

11040

Pfizer Investigational Site, New Hyde Park

13125

Pfizer Investigational Site, Berlin

15904

Pfizer Investigational Site, Johnstown

16601

Pfizer Investigational Site, Altoona

16602

Pfizer Investigational Site, Altoona

16635

Pfizer Investigational Site, Duncansville

17033

Pfizer Investigational Site, Hershey

17604

Pfizer Investigational Site, Lancaster

22081

Pfizer Investigational Site, Hamburg

28009

Pfizer Investigational Site, Madrid

28034

Pfizer Investigational Site, Madrid

28205

Pfizer Investigational Site, Bremen

30625

Pfizer Investigational Site, Hanover

33155

Pfizer Investigational Site, Miami

33484

Pfizer Investigational Site, Delray Beach

33701

Pfizer Investigational Site, St. Petersburg

44650

Pfizer Investigational Site, Guadalajara

46009

Pfizer Investigational Site, Valencia

46410

Pfizer Investigational Site, Merrillville

53201

Pfizer Investigational Site, Milwaukee

54511

Pfizer Investigational Site, Vandœuvre-lès-Nancy

60025

Pfizer Investigational Site, Glenview

60521

Pfizer Investigational Site, Hinsdale

60614

Pfizer Investigational Site, Chicago

60637

Pfizer Investigational Site, Chicago

60649

Pfizer Investigational Site, Chicago

64460

Pfizer Investigational Site, Monterrey

68178

Pfizer Investigational Site, Omaha

70118

Pfizer Investigational Site, New Orleans

74133

Pfizer Investigational Site, Tulsa

74135

Pfizer Investigational Site, Tulsa

92123

Pfizer Investigational Site, San Diego

97210

Pfizer Investigational Site, Portland

97232

Pfizer Investigational Site, Portland

115522

Pfizer Investigational Site, Moscow

119296

Pfizer Investigational Site, Moscow

06106

Pfizer Investigational Site, Hartford

02115

Pfizer Investigational Site, Boston

01610

Pfizer Investigational Site, Worcester

07039

Pfizer Investigational Site, Livingston

97227-1623

Pfizer Investigational Site, Portland

53226-0509

Pfizer Investigational Site, Milwaukee

20551-030

Pfizer Investigational Site, Rio de Janeiro

21944-970

Pfizer Investigational Site, Rio de Janeiro

04025-002

Pfizer Investigational Site, São Paulo

05403-901

Pfizer Investigational Site, São Paulo

Unknown

Pfizer Investigational Site, Saskatoon

06120

Pfizer Investigational Site, Halle

L05

Pfizer Investigational Site, Lima

L13

Pfizer Investigational Site, Lima

L31

Pfizer Investigational Site, Lima

4764-901

Pfizer Investigational Site, Vila Nova de Famalicão

921 01

Pfizer Investigational Site, Piešťany

SE-17176

Pfizer Investigational Site, Stockholm

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Pfizer

INDUSTRY

NCT00652925 - A Study to Evaluate the Efficacy and Safety of Celecoxib Suspension Compared to Naproxen Suspension in Patients With JRA | Biotech Hunter | Biotech Hunter